|

Ladarixin Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • NYU Langone Health1

Indications

  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation1
  • Lung Cancer1
  • Cancer1

Garden City, New York1 trial

Ladarixin With Sotorasib in Advanced NSCLC

NYU Langone Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.